Table 3.

Comparison between mortality and the pharmacological treatments used in patients hospitalized with COVID-19 (multivariate analysis).

Severity	Treatment	Deceased (%)	Alive (%)	Total (%)	P value	OR, 95% CI
Critic n = 112	Antibiotics + LMWH + corticosteroids	15 (93.8)	1 (6.2)	16 (14.3)	0.0087**	15 (3.04–271.2)
	Antibiotics + LMWH + corticosteroids + colchicine	45 (83.3)	9 (16.7)	54 (48.2)	0.32	0.3 (0.017–2)
	LMWH + corticosteroids	10 (90.1)	1 (0.9)	11 (9.8)	0.78	0.667 (0.024–18.2)
	LMWH + corticosteroids + colchicine	7 (87.5)	1 (12.5)	8 (7.1)	0.61	0.47 (0.017–12.9)
	Other treatment	17 (73.9)	6 (26.1)	23 (20.5)	0.14	0.19 (0.009–1.28)
Moderate n = 87	Antibiotics + LMWH + corticosteroids	1 (25)	3 (75)	4 (4.6)	0.34	0.333, (0.016–2.6)
	Antibiotics + LMWH + corticosteroids + colchicine	2 (4.7)	41 (95.3)	43 (49.4)	0.16	0.146 (0.010–3.66)
	LMWH + corticosteroids	1 (12.5)	7 (87.5)	8 (9.2)	0.59	0.43 (0.013–13.33)
	LMWH + corticosteroids + colchicine	1 (20)	4 (80)	5 (5.7)	0.86	0.75 (0.022–24.66)
	Other treatment	4 (14.8)	23 (85.2)	27 (31)	0.61	0.52 (0.05–12)
Severe n = 10	Antibiotics + LMWH + corticosteroids	2 (66.7)	1 (33.3)	3 (30)	0.57	2 (0.191–4.3)
	Antibiotics + LMWH + corticosteroids + colchicine	1 (50)	1 (50)	2	0.71	0.5 (0.008–2.3)
	LMWH + corticosteroids	0	2 (100)	2 (20)	0.997	0 (NA–1472)
	LMWH + corticosteroids + colchicine	0	1 (100)	1 (10)	0.998	0 (NA–NA)
	Other treatment	1 (50)	1 (50)	2 (20)	0.711	0.5 (0.008–2.35)
All patients hospitalized n = 209	Antibiotics + LMWH + corticosteroids	18 (78.3)	5 (21.7)	23 (11)	0.0113*	3.6 (1.437–10.9)
	Antibiotics + LMWH + corticosteroids + colchicine	48 (48)	51 (52)	99 (47.4)	0.014*	0.26 (0.08-0.71)
	LMWH + corticosteroids	11 (52.4)	10 (47.6)	21 (10)	0.08	0.3 (0.07-0.09)
	LMWH + corticosteroids + colchicine	8 (57.1)	6 (42.8)	14 (6.7)	0.18	0.37 (0.08-0.57)
	Other treatment	22 (42.3)	30 (57.7)	52 (24.9)	0.006*	0.2 (0.06-0.6)

NA: not apply.

^*Statistical differences; 122 (58%) received antimicrobial treatment, 157 (75%) LMWH.